Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 50
Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation A Committee and Staff Biographies COMMITTEE MEMBERS Joshua Lederberg (NAS, IOM), chair, is Professor Emeritus and Raymond and Beverly Sackler Foundation Scholar at the Rockefeller University. In 1958 he received the Nobel Prize in Physiology or Medicine for his work in bacterial genetics. He has been active in many national and international science policy deliberations, especially at the National Institutes of Health (NIH) and World Health Organization (WHO). He served as a consultant to the Arms Control and Disarmament Agency during negotiation of the 1972 Biological and Toxin Weapons Convention (BWC), and he currently serves on the Defense Science Board. John D. Steinbruner, vice-chair, is a Senior Fellow and former Director of the Foreign Policy Studies Program at the Brookings Institution. He has held faculty positions at Yale University, Harvard University, and Massachusetts Institute of Technology. A political scientist, he has written extensively on arms control and security issues, including problems of command and control and crisis decision making. He is a member of the Defense Policy Board. Barry Bloom (NAS, IOM) is Investigator at the Howard Hughes Medical Institute of the Albert Einstein College of Medicine. He has received numerous awards for his work in immunology and infectious diseases, including the Bristol-Myers Squibb Award. He has been active in the programs of WHO. Gail Cassell (IOM) is Chair of the Department of Microbiology and Charles H. McCauley Professor of Microbiology at the University of Alabama-Birmingham. She has received a number of awards for her research in infectious diseases and is a recent past President of the American Society for Microbiology. She has been active in national and international policy deliberations, including those of NIH and the U.S.-Japan Cooperative Medical Science Program. She is also a member of the International Science and Technology Center Science Advisory Committee and a member of the steering committee for the U.S.-Japan Cooperative Medical Science Program. She is a recent chair of the Board of Scientific Counselors of the National Center for Infectious Diseases of the Centers for Disease Control and Prevention (CDC). Robert Chanock (NAS) is Chief of the Laboratory of Infectious Diseases of the National Institute of Allergy and Infectious Diseases of NIH. He has received numerous awards for his work in virology and infectious disease research, including the Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research, the Robert Koch Medal of the Robert Koch Foundation, the ICN International Prize in Virology, and the Albert Sabin Gold Medal of the Albert Sabin Vaccine Foundation. He has been active in WHO and in national policy discussions. R. John Collier (NAS) is Professor of Microbiology and Molecular Genetics at Harvard Medical School. His career has been largely devoted to research on the structures and actions of bacterial toxins. He has received a number of awards during his career including the Eli Lilly Award in Microbiology and Immunology and the Paul Ehrlich Prize.
OCR for page 51
Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation Maurice R. Hilleman (NAS) is Director (formerly Senior Vice President) of the Merck Institute at Merck Research Laboratories in West Point, Pennsylvania. His career has been in basic and applied research on viruses, vaccines, immunology, and cancer. He is a long-time adviser to many health agencies including the Department of Health and Human Services, WHO, Overseas Medical Research Laboratory Committee of the Department of Defense (DOD), and special committees of the NAS and IOM. Peter B. Jahrling is Scientific Adviser and Senior Research Scientist at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). He is head of the WHO collaborating center on arbovirus and hemorrhagic fever virus research at USAMRIID and a member of the Committee on Return of Biological Samples of the National Research Council's (NRC 's) Space Studies Board. He serves as a guest editor for a number of journals including the third and fourth editions of the Biosafety in Microbiological and Biomedical Laboratories. His research interests include development of vaccines, antiviral drugs, and effective treatment strategies for Ebola, Marburg, Lassa, and orthopox viruses. James Leduc is Associate Director for Global Health in the National Center for Infectious Diseases at CDC. He is a fellow of the American College of Epidemiology and has received numerous awards for outstanding work in epidemiology. He has served as a Medical Officer of WHO and as an Officer at the United States Army Medical Research and Development Command. His research interests include epidemiology of virus diseases, especially viral hemorrhagic fevers and new, emerging and reemerging diseases. Matthew Meselson (NAS, IOM) is Thomas Dudley Cabot Professor of Natural Sciences at Harvard University and codirector of the Harvard-Sussex program on chemical and biological warfare armament and arms limitation. He has conducted research mainly in the field of molecular genetics and is recipient of the NAS Award in Molecular Biology, the Eli Lilly Award in Microbiology, and the Thomas Hunt Morgan Medal of the Genetics Society of America. He is a member of the Royal Society and the Academie des Sciences and has served as a consultant on chemical and biological weapons matters to U.S. government agencies. Thomas Monath is Vice President of Research and Development at OraVax and Adjunct Professor at the Harvard School of Public Health. He has been engaged in programs of WHO and the National Vaccines Advisory Committee. He was formerly director of the Division of Vector-Borne Infectious Diseases, CDC, and Chief of Virology, USAMRIID. His research has included work on arboviruses, viral hemorrhagic fevers, bubonic plague, and other zoonotic diseases. He has served on various committees dealing with biological weapons (BW) issues. Frederick A. Murphy is Professor at the School of Veterinary Medicine at the University of California-Davis. Formerly, he was dean of the school and earlier he was the director of the National Center for Infectious Diseases at CDC. He is recipient of the Presidential Rank Award and is a member of the German Academy of Natural Sciences. He has been a leader in viral pathogenesis, viral characterization, and taxonomy; his interests include public health policy, vaccine development, and new, emerging and reemerging diseases. Major General Philip K. Russell (retired U.S. Army) is Professor of International Health at the School of Hygiene and Public Health, Johns Hopkins University. He received the Distinguished Service Medal before retiring from military service. He has served on numerous scientific committees including advisory committees to the CDC and WHO. He was also involved in the establishment of medical research facilities at military bases around the world.
OCR for page 52
Controlling Dangerous Pathogens: A Blueprint for U.S.-Russian Cooperation Alexis Shelokov is Director of Medical Affairs with the Biologicals Development Center of the Salk Institute. He served as a member of the Expert Working Group on Biological and Toxin Weapons Verification of the Federation of American Scientists. He has been involved in the activities of WHO, NIH, and the U.S.-Japan Cooperative Medical Program. In addition, he served as the chairman of U.S. delegations on hemorrhagic fevers to the Soviet Union in 1965 and 1969. STAFF MEMBERS Christopher P. Howson is Director of the Board on International Health of the IOM. In his 11 years at NAS, he has directed 15 projects and in 1993 served as acting director of the IOM Medical Follow-up Agency. Before coming to NAS, he was senior epidemiologist at the American Health Foundation in New York City. He holds a Ph.D. in epidemiology from the University of California at Los Angeles. Jo L. Husbands is Director of the NAS Committee on International Security and Arms Control. Before assuming that position, she was director of the NRC 's Project on Democratization and senior research associate for its Committee on International Conflict and Cooperation. She holds a Ph.D. in political science from the University of Minnesota. Glenn E. Schweitzer is Director of the Office for Central Europe and Eurasia of the National Research Council. From 1963 to 1966, he served as the first science officer at the American Embassy in Moscow, and from 1992 to 1994 he was the first executive director of the International Science and Technology Center in Moscow. He has also served as director of the Office of Toxic Substances and director of the Environmental Monitoring Systems Laboratory-Las Vegas of the U.S. Environmental Protection Agency. Chaarles G. Fogelgren is Research Assistant for the NAS Committee on International Security and Arms Control. He holds a B.A. in anthropology from The George Washington University. His interests include chemical and biological weapons disarmament, evolution, ethics, parasitology, and emerging and reemerging diseases.
Representative terms from entire chapter: